Zelakot M16 Tablet

Zelakot M16 Tablet Specification

Brand Name
Zelakot M16

Indication
Allergy, asthma, and inflammatory conditions

Packaging Type
Blister pack

Life Span
24 months from date of manufacture

Dosage Form
Oral Tablet

Origin of Medicine
India

Salt Composition
Deflazacort and Montelukast

Pacakaging (Quantity Per Box)
10 strips per box

Drug Type
Prescription Only

Ingredients
Deflazacort 6 mg, Montelukast 10 mg

Physical Form
Tablet

Function
Used to treat inflammatory and allergic conditions

Recommended For
Adults and children as prescribed by physician

Dosage
As directed by the physician

Dosage Guidelines
Take the tablet with water, do not exceed recommended dose

Suitable For
Suitable for adults and older children

Quantity
10 tablets per strip

Storage Instructions
Store in a cool, dry place away from sunlight

Shelf Life
2 years

Route of Administration
Oral

Prescription Status
Prescription required

Shape
Oval, film-coated

Therapeutic Class
Corticosteroid and Leukotriene Receptor Antagonist

Color
White to off-white

Caution
Not to be used during pregnancy or lactation unless prescribed

Zelakot M16 Tablet Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

About Zelakot M16 Tablet

Select the Zelakot M16 Tablet for an exquisite combination of valuable corticosteroid and leukotriene receptor antagonist therapy. This kingly blend unites Deflazacort 6 mg and Montelukast 10 mg in a new, oval, film-coated tablet, offering savings in both effort and efficacy when managing allergy, asthma, and inflammatory conditions. Suitable for adults and older children, Zelakot M16 is available in a prescription-only, blister pack of 10 tablets per strip. Ensure proper usage under medical supervision. Store in a cool, dry place and always adhere to recommended dosage for optimum results.

Applications and Areas of Use for Zelakot M16 Tablet

Zelakot M16 Tablet is indicated for use in allergy, asthma, and various inflammatory conditions, making it highly versatile for both respiratory and allergic disorders. Its site of application is systemic, taken orally to deliver relief throughout the body. This formulation is valuable in hospitals, clinics, and home settings under medical advice. It can be considered for use where comprehensive anti-inflammatory action and allergy management are required as prescribed by healthcare professionals.

Certifications, Market, and Swift Supply of Zelakot M16 Tablet

Our Zelakot M16 Tablet is manufactured in India, conforming to stringent pharmaceutical certifications and quality standards. Serving the main domestic market across the country, we offer timely delivery and responsive supply options for distributors and traders. Upon quotation request, clients can receive packaging details-10 strips per box-and expect swift processing and shipment. We focus on reliability and regulatory compliance in every transaction, whether for export or domestic supply channels.

FAQ's of Zelakot M16 Tablet:

Q: How should Zelakot M16 Tablet be used for optimal effectiveness?

A: Take Zelakot M16 Tablet orally with water, following the dosage and directions prescribed by your physician. Do not exceed the recommended dose.

Q: What conditions are treated with Zelakot M16 Tablet?

A: Zelakot M16 Tablet is used to manage inflammatory and allergic conditions such as asthma, allergies, and other related disorders requiring corticosteroid and leukotriene antagonist therapy.

Q: When is it recommended to avoid using Zelakot M16 Tablet?

A: This medication should not be used during pregnancy or lactation unless specifically prescribed by a healthcare professional.

Q: Where should Zelakot M16 Tablet be stored?

A: Store Zelakot M16 in a cool, dry place away from direct sunlight to maintain its efficacy and extend its shelf life.

Q: What are the benefits of using Zelakot M16 Tablet as prescribed?

A: When used as directed, Zelakot M16 provides effective control over allergies and inflammation, offering relief and improving the quality of life for patients.